Parta M - Search Results

1

Paravertebral mushroom: identification of a novel species of Phellinus as a human pathogen in chronic granulomatous disease.

De Ravin SS, Parta M, Sutton DA, Wickes BL, Thompson EH, Wiederhold NP, Nakasone KK, Alimchandani M, OConnell A, Notarangelo L, Kang E, Malech HL, Zelazny AM. De Ravin SS, et al. Among authors: parta m. J Clin Microbiol. 2014 Jul;52(7):2726-9. doi: 10.1128/JCM.00667-14. Epub 2014 May 14. J Clin Microbiol. 2014. PMID: 24829241 Free PMC article.

2

Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report.

Parta M, Hilligoss D, Kelly C, Kwatemaa N, Theobald N, Malech H, Kang EM. Parta M, et al. J Clin Immunol. 2015 Oct;35(7):675-80. doi: 10.1007/s10875-015-0204-y. Epub 2015 Oct 9. J Clin Immunol. 2015. PMID: 26453586 Free PMC article.

3

Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.

Parta M, Kelly C, Kwatemaa N, Theobald N, Hilligoss D, Qin J, Kuhns DB, Zerbe C, Holland SM, Malech H, Kang EM. Parta M, et al. J Clin Immunol. 2017 Aug;37(6):548-558. doi: 10.1007/s10875-017-0422-6. Epub 2017 Jul 28. J Clin Immunol. 2017. PMID: 28752258 Free PMC article.

4

Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.

Dimitrova D, Gea-Banacloche J, Steinberg SM, Sadler JL, Hicks SN, Carroll E, Wilder JS, Parta M, Skeffington L, Hughes TE, Blau JE, Broadney MM, Rose JJ, Hsu AP, Fletcher R, Nunes NS, Yan XY, Telford WG, Kapoor V, Cohen JI, Freeman AF, Garabedian E, Holland SM, Lisco A, Malech HL, Notarangelo LD, Sereti I, Shah NN, Uzel G, Zerbe CS, Fowler DH, Gress RE, Kanakry CG, Kanakry JA. Dimitrova D, et al. Among authors: parta m. Biol Blood Marrow Transplant. 2020 Jan;26(1):94-106. doi: 10.1016/j.bbmt.2019.08.018. Epub 2019 Sep 4. Biol Blood Marrow Transplant. 2020. PMID: 31493539 Free PMC article. Clinical Trial.

5

Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease.

Parta M, Hilligoss D, Kelly C, Kwatemaa N, Theobald N, Zerbe CS, Holland SM, Malech HL, Kang EM. Parta M, et al. J Clin Immunol. 2020 May;40(4):619-624. doi: 10.1007/s10875-020-00772-z. Epub 2020 Apr 20. J Clin Immunol. 2020. PMID: 32314173 Free PMC article.

6

Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency.

Nichols-Vinueza DX, Parta M, Shah NN, Cuellar-Rodriguez JM, Bauer TR Jr, West RR, Hsu AP, Calvo KR, Steinberg SM, Notarangelo LD, Holland SM, Hickstein DD. Nichols-Vinueza DX, et al. Among authors: parta m. Br J Haematol. 2022 Jan;196(1):169-178. doi: 10.1111/bjh.17840. Epub 2021 Sep 27. Br J Haematol. 2022. PMID: 34580862 Free PMC article.

7

Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease.

Parta M, Cuellar-Rodriguez J, Gea-Banacloche J, Qin J, Kelly C, Zerbe CS, Holland SM, Malech HL, Kang EM. Parta M, et al. Transpl Infect Dis. 2022 Apr;24(2):e13815. doi: 10.1111/tid.13815. Epub 2022 Mar 10. Transpl Infect Dis. 2022. PMID: 35191140 Free PMC article.

8

Hematopoietic Stem Cell Transplantation in Late-onset X-linked Chronic Granulomatous Disease in a Female Carrier.

Trevisan M, Kang EM; CGD Consortium; Tommasini A, Confalonieri M. Trevisan M, et al. J Clin Immunol. 2022 Oct;42(7):1396-1399. doi: 10.1007/s10875-022-01310-9. Epub 2022 Jun 30. J Clin Immunol. 2022. PMID: 35771399 Free PMC article. No abstract available.

9

Correction to: Hematopoietic Stem Cell Transplantation in late-onset X-linked Chronic Granulomatous Disease in a female carrier.

Trevisan M, Kang EM; CGD Consortium; Tommasini A, Confalonieri M. Trevisan M, et al. J Clin Immunol. 2022 Oct;42(7):1400. doi: 10.1007/s10875-022-01334-1. J Clin Immunol. 2022. PMID: 35951147 No abstract available.

10

Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study.

Grunebaum E, Arnold DE, Logan B, Parikh S, Marsh RA, Griffith LM, Mallhi K, Chellapandian D, Lim SS, Deal CL, Kapoor N, Murguía-Favela L, Falcone EL, Prasad VK, Touzot F, Bleesing JJ, Chandrakasan S, Heimall JR, Bednarski JJ, Broglie LA, Chong HJ, Kapadia M, Prockop S, Dávila Saldaña BJ, Schaefer E, Bauchat AL, Teira P, Chandra S, Parta M, Cowan MJ, Dvorak CC, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson TR, Malech HL, Kang EM, Leiding JW. Grunebaum E, et al. Among authors: parta m. J Allergy Clin Immunol. 2024 May;153(5):1423-1431.e2. doi: 10.1016/j.jaci.2024.01.013. Epub 2024 Jan 28. J Allergy Clin Immunol. 2024. PMID: 38290608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page